Experiences with
Prialt5,501 public posts
The Truth About Liver Cancer: Future Topics
Hello everyone,
We're having our first [i]The Truth About Liver Cancer[/i] workshop on Saturday, March 15, at 12 p.m. ET. The topic is Patient Perspectives. You'll meet three people who have or had different liver diseases that put them at a high risk for liver cancer.
You can register
Want to take advantage of all our features? Just log in!
or
BTK Is the Target That Keeps on Giving: A Review of BTK-Degrader Drug Development, Clinical Data, and Future Directions in CLL
Here's a welcome article that explains all about BTK degraders; the next class of BTK drug after the success of the FDA approved covalent BTKis (acalabrutinib/Calquence, ibrutinib/Imbruvica and zanubrutinib/Brukinsa) and non-covalent BTKi pirtobrutinib/Jaypirca.
[i][/i]
[i]"Oral therapies targeting